Abstract

PurposeWe evaluated the feasibility of electronic portal imaging based 3D in-vivo dosimetry for stereotactic body radiation therapy (SBRT) technique in prostate cancer. Methods and materialsTo investigate error detectability limitations of iViewDose™ v.1.0.1 (Elekta, Stockholm, Sweden) for prostate SBRT cases, ten prostate cancer patients were selected and in-vivo electronic portal imaging devices dosimetry was performed. Also possible error scenarios including dose calibration, setup, collimator, multi leaf collimator and patient anatomy related inaccuracies were created to investigate detectability of EPID. For this purpose, a SBRT treatment was planned on BrainLab pelvis phantom (BrainLab Medical Systems, Westchester, IL) and irradiated after proving setup with cone beam computer tomography. After that incorrect plans were irradiated and obtained results were compared with original in vivo measurements. ResultsMean gamma analysis (γ% ≤ 1) passing rate of ten patients was found as 96.2%. Additionally, mean dose reference point difference between measurement and calculated in treatment planning system for clinical target volume, rectum, bladder, left and right femur heads were found as 1.4%, 8%, 20.8%, 2.3% and 4.5%, respectively. Phantom measurements showed that positional errors can be escape from detection. However, the incorrect treated plans including linac calibration, MLC positions and patient anatomy based errors could not have passed the in vivo dosimetry analysis. Conclusions: EPID-based 3D in vivo dosimetry software (iViewDose) provides an efficient safety check on the accuracy of dose delivery during prostate SBRT treatments. However, phantom results showed some limitation of the system.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.